MEDS logo

DATAMEDS AI INC

MEDSNASDAQ
🏆 #4831 by market capUS Equity
$2.20▲ $0.14 (+6.80%)
Market closed · at close
🔔
Track MEDS
Get earnings, price moves & breaking news on Telegram
Track
24h▲ 6.8%
7d▼ 3.9%
14d▼ 21.8%
30d▼ 39.6%
ytd▼ 88.6%
1y▼ 93.0%
🏦Market Cap
$10M
Small Cap
📈Revenue Growth (YoY)
28.7%
High Growth
📊Gross Margin
-125.1%
Thin
💵FCF Margin
-169.3%
Thin
⚖️P/S Ratio
1.2x
Cheap
Otter Score
—
Insufficient data

Trading Snapshot

Day Range
$2.00 – $2.27
52-Week Range
$0.82 – $40.85
Volume (shares)
343,952
Avg Volume (shares)
—
Shares Outstanding
4.5M
Next Earnings
—

Fundamentals Snapshot

Annual Revenue
$23M
Last Q Revenue
$2M
P/E Ratio
-0.0
P/S Ratio
1.2x
EPS (TTM)
$-34.29
Dividend Yield
0.00%
Dilution (1yr)
+36.7%
MEDS logo

DATAMEDS AI INC

MEDS
Financial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$23M▲ +28.7% YoY
Gross MarginOf every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
-41.3%▼ −523.6% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
−$81M▲ +1221.3% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
−$11M▲ +577.5% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing owner’s slice.
1.4M▲ +36.7% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
−$25M▼ −$645K YoY
StockOtter · stockotter.space

About DATAMEDS AI INC

DataMEDS AI is a Health IT company focused on the vertical integration of technology, pharmacy, pharmaceutical-adjacent, and telemedicine business units. The company incorporates its artificial intelligence platform EinsteinRx™ and blockchain-enabled smart contacts platform PharmacyChain™ to optimize the prescription medicines reimbursement and dispensing journey.

🦦

Otter Score Breakdown

How it's scoredFive components, each rated 1–5★ and equally weighted (20%), averaged to a 0–100 score:💎 Quality — gross margin🚀 Growth — revenue YoY⚖️ Valuation — P/S ratio⚡ Momentum — 30-day price change💧 Dilution — 1-yr share issuance (buybacks score higher)

Insufficient data for all five components.

💎Quality★★★★★
🚀Growth★★★★★
⚖️Valuation★★★★★
💧Dilution★★★★★
Overall Score
Insufficient data
—/100
Analyst data unavailable.

Latest News & Updates

Accesswire·6d ago

DataMEDS AI Establishes "Health Lives Here" Community Respiratory Program for Corexa Health Pharmacy Network

Being marketed to 6,500+ Corexa Health Pharmacy Network of independent pharmacies To be launched first at Corexa Pharmacy in Lakeland, FL retail location in Q4/2026 Program will aim to bring best practices for respirator

Business Wire·6d ago

Datavault AI Signs Non-Binding Letter of Intent to Acquire a 19.9% Equity Stake in DataMEDS AI in Consideration of an Expanded Technology License

PHILADELPHIA--(BUSINESS WIRE)--Datavault AI Inc. (“Datavault AI” or the “Company”) (Nasdaq: DVLT), an Artificial Intelligence Platform (“AIP”) company providing data monetization, credentialing, and real-world asset (“RW

Accesswire·6d ago

DataMEDS AI Enters Into Amended and Restated LOI to License and Acquire IP that Enables Goal-Driven Prescription Drug Telehealth, Medical Drones and Healthcare Blockchain Technologies

Proprietary IP Position Until At Least 2042 to Enable Consolidation of Infrastructure targeting market expected to grow from $9.6 billion in 2025 to $93.4 billion in 2035 Customer Acquisition Plan Leverages Existing Rela

Accesswire·9d ago

DataMeds Regains Compliance With NASDAQ Listing Standards

TAMPA, FL / ACCESS Newswire / October 20, 2026 / DataMeds AI, Inc. (NASDAQ:MEDS) ("DataMeds AI," "DataMEDS SI," "DataMEDS," or the "Company"), a healthcare company leveraging its Health IT and physical infrastructure tog

Defense World·11d ago

Contrasting Wellgistics Health (NASDAQ:MEDS) & Hims & Hers Health (NYSE:HIMS)

Wellgistics Health (NASDAQ: MEDS - Get Free Report) and Hims and Hers Health (NYSE: HIMS - Get Free Report) are both healthcare companies, but which is the better business? We will contrast the two businesses based on th

Accesswire·13d ago

DataMeds Applauds FDA's Proposed Interim Access Policy for Compounding Using Certain Peptides and Provides Corexa Health's Peptides Roadmap

Corexa Health's three divisions - pharmacy, distribution, and tech & hub - positioned to serve the emerging compounded peptide market TAMPA, FL / ACCESS Newswire / October 16, 2026 / DataMeds AI, Inc. (NASDAQ:MEDS) ("Dat